Athersys Inc.

ATHX on NASDAQToday's ChangeVolume52 Week Range (Low/Hi)Market Cap
1.45US -0.02/-1.36%367,9171.20 / 2.23221.38 M

Contact Information

Athersys Inc.

Headquarters:
3201 Carnegie Avenue,
Cleveland, Ohio
USA, 44115
Tel: 216-431-9900
Fax: 216-361-9495
Email: Send a message
Website: Visit website
For more information...
Lead: Robert Thaemlitz
Oct 10, 2019 - 12:00 PM CDT Corporate Presentation - Minneapolis
Oct 16, 2019 - 1:00 PM PDT Corporate Presentation - San Francisco
Oct 17, 2019 - 1:00 PM PDT Corporate Presentation - Los Angeles

Athersys is an international biotechnology company engaged in the discovery and development of therapeutic product candidates designed to extend and enhance the quality of human life. The Company is developing its MultiStem cell therapy product, a patented, adult-derived "off-the-shelf" stem cell product, initially for disease indications in the neurological, inflammatory and immune, cardiovascular and other critical care indications, and has several ongoing clinical trials evaluating this potential regenerative medicine product. Athersys has forged strategic partnerships and a broad network of collaborations to further advance the MultiStem cell therapy toward commercialization.  More information is available at www.athersys.com.

Gil Van Bokkelen Ph.D. - Chairman & Chief Executive Officer

John Harrington Ph.D. - Executive Vice President & Chief Scientific Officer

William (B.J.) Lehmann J.D. - President & Chief Operating Officer

Laura K. Campbell C.P.A. - Senior Vice President of Finance

Manal Morsy MD Ph.D. - Senior Vice President & Head of Global Regulatory Affairs

Greg Liposky, MBA - Senior Vice President Commercial Manufacturing

Robert (Willie) Mays Ph.D. - Vice President of Regenerative Medicine & Head of Neuroscience Programs

Anthony Ting Ph.D. - Vice President of Regenerative Medicine & Head of Cardiopulmonary Programs

Rakesh Ramachandran MS - Vice President & Head of Information Technology & Communications

Raymond Starling Ph.D. - Vice President of Clinical Development & Operations

Gil Van Bokkelen Ph.D. - Chairman and CEO

Lee Babiss Ph.D. - Director

John Harrington Ph.D. - Director

Hardy TS Kagimoto M.D - Director

Ismail Kola Ph.D. - Director

Lorin J Randall - Director

Jack L Wyszomierski - Director
 

Stock Information

Events

Oct 10, 2019 - 12:00 PM CDT Corporate Presentation - Minneapolis
Oct 16, 2019 - 1:00 PM PDT Corporate Presentation - San Francisco
Oct 17, 2019 - 1:00 PM PDT Corporate Presentation - Los Angeles

Company Overview

Athersys is an international biotechnology company engaged in the discovery and development of therapeutic product candidates designed to extend and enhance the quality of human life. The Company is developing its MultiStem cell therapy product, a patented, adult-derived "off-the-shelf" stem cell product, initially for disease indications in the neurological, inflammatory and immune, cardiovascular and other critical care indications, and has several ongoing clinical trials evaluating this potential regenerative medicine product. Athersys has forged strategic partnerships and a broad network of collaborations to further advance the MultiStem cell therapy toward commercialization.  More information is available at www.athersys.com.

Management

Gil Van Bokkelen Ph.D. - Chairman & Chief Executive Officer

John Harrington Ph.D. - Executive Vice President & Chief Scientific Officer

William (B.J.) Lehmann J.D. - President & Chief Operating Officer

Laura K. Campbell C.P.A. - Senior Vice President of Finance

Manal Morsy MD Ph.D. - Senior Vice President & Head of Global Regulatory Affairs

Greg Liposky, MBA - Senior Vice President Commercial Manufacturing

Robert (Willie) Mays Ph.D. - Vice President of Regenerative Medicine & Head of Neuroscience Programs

Anthony Ting Ph.D. - Vice President of Regenerative Medicine & Head of Cardiopulmonary Programs

Rakesh Ramachandran MS - Vice President & Head of Information Technology & Communications

Raymond Starling Ph.D. - Vice President of Clinical Development & Operations

Board of Directors

Gil Van Bokkelen Ph.D. - Chairman and CEO

Lee Babiss Ph.D. - Director

John Harrington Ph.D. - Director

Hardy TS Kagimoto M.D - Director

Ismail Kola Ph.D. - Director

Lorin J Randall - Director

Jack L Wyszomierski - Director
 

Contact Information

Headquarters:
3201 Carnegie Avenue,
Cleveland, Ohio
44115, USA
Telephone: 216-431-9900
Fax: 216-361-9495
Email: Send a message
Website: Visit website